Novartis has entered into a grant agreement with the Bill & Melinda Gates Foundation to fund the development of accessible single use gene therapies to cure sickle cell disease (SCD), the ...

EAST HANOVER, N.J., Sept. 16, 2020 /PRNewswire/ -- Today the Novartis US Foundation announced a total commitment of USD 25 million to develop partnerships and fund community organizations and ...

The Novartis US Foundation on Thursday announced a commitment of $25 million to develop partnerships and fund community organizations and programs in the United States that address health ...

Novartis is adding sickle cell disease to its gene therapy stable through a partnership with the Bill & Melinda Gates Foundation. The latter will support a research team at the Swiss Pharma ...

Novartis has been in the forefront of the clash, as it gears up for a fresh defence of its patents in India for Glivec, a costly cancer drug. Jeff Raikes, chief executive of the Gates Foundation ...

(RTTNews) - Novartis AG (NVS) and the Bill & Melinda Gates Foundation have collaborated to discover and develop an accessible in vivo gene therapy for sickle cell disease, the Swiss multinational ...

(RTTNews) - Novartis AG (NVS) and the Bill & Melinda Gates Foundation have collaborated to discover and develop an accessible in vivo gene therapy for sickle cell disease, the Swiss multinational ...